| Dr Charles A Richardson, MD | |
|
600 S Dobson Rd, Suite E-39, Chandler, AZ 85224-5678 | |
| (480) 777-5888 | |
| (480) 777-8996 |
| Full Name | Dr Charles A Richardson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 39 Years |
| Location | 600 S Dobson Rd, Chandler, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215085642 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 41822 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoenician Medical Center Inc | 0547169708 | 34 |
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Revolutions Medical Corporation has notified the MDEA that there had been an error in awarding the Free Vac syringe the 2010 Medical Design Excellence Award when in fact Free Vac misrepresented ownership of the syringe. The syringe was actually Revolutions Medical Corporation's RevVac auto retractable safety syringe.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
The way prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation, reveals a study published in PLoS Genetics today (Thursday).
An enzyme that usually triggers strong allergic reactions now circulates in the veins of a group of mice without alerting the immune system. As INRS Énergie Matériaux Télécommunications Research Centre Professor Marc A. Gauthier explains in an article published in the journal Nature Communications, a polymer was used to camouflage the enzyme before it was injected into the rodents. This was achieved by coating the enzyme to avoid an immune response in a manner that does not compromise its activity.
› Verified 4 days ago
| Entity Name | Phoenician Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891895637 PECOS PAC ID: 0547169708 Enrollment ID: O20040107000237 |
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Revolutions Medical Corporation has notified the MDEA that there had been an error in awarding the Free Vac syringe the 2010 Medical Design Excellence Award when in fact Free Vac misrepresented ownership of the syringe. The syringe was actually Revolutions Medical Corporation's RevVac auto retractable safety syringe.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
The way prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation, reveals a study published in PLoS Genetics today (Thursday).
An enzyme that usually triggers strong allergic reactions now circulates in the veins of a group of mice without alerting the immune system. As INRS Énergie Matériaux Télécommunications Research Centre Professor Marc A. Gauthier explains in an article published in the journal Nature Communications, a polymer was used to camouflage the enzyme before it was injected into the rodents. This was achieved by coating the enzyme to avoid an immune response in a manner that does not compromise its activity.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles A Richardson, MD 2929 E Thomas Rd, Phoenix, AZ 85016-8034 Ph: (602) 470-5000 | Dr Charles A Richardson, MD 600 S Dobson Rd, Suite E-39, Chandler, AZ 85224-5678 Ph: (480) 777-5888 |
News Archive
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Revolutions Medical Corporation has notified the MDEA that there had been an error in awarding the Free Vac syringe the 2010 Medical Design Excellence Award when in fact Free Vac misrepresented ownership of the syringe. The syringe was actually Revolutions Medical Corporation's RevVac auto retractable safety syringe.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
The way prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation, reveals a study published in PLoS Genetics today (Thursday).
An enzyme that usually triggers strong allergic reactions now circulates in the veins of a group of mice without alerting the immune system. As INRS Énergie Matériaux Télécommunications Research Centre Professor Marc A. Gauthier explains in an article published in the journal Nature Communications, a polymer was used to camouflage the enzyme before it was injected into the rodents. This was achieved by coating the enzyme to avoid an immune response in a manner that does not compromise its activity.
› Verified 4 days ago
Dr. David Bebawy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 S Alma School Rd, Chandler, AZ 85286 Phone: 480-256-7420 Fax: 480-646-3826 | |
Heidi U Rula, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 685 S Dobson Road, Chandler, AZ 85224 Phone: 480-821-2838 Fax: 480-821-9444 | |
Srilakshmi Settipalli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 811 S Hamilton St, Chandler, AZ 85225 Phone: 480-344-6100 Fax: 480-344-6101 | |
Lorretta K Mccarthy, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3960 E Riggs Rd, Suite 1, Chandler, AZ 85249 Phone: 480-786-4441 Fax: 480-786-4609 | |
Kurt Henry Steinke, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1343 N Alma School Rd Ste 160, Chandler, AZ 85224 Phone: 480-963-1853 Fax: 480-726-0695 | |
Neha Maheshwari, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1343 N Alma School Rd, 205, Chandler, AZ 85224 Phone: 480-963-1853 | |
Stephan Zehring, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1435 S Alma School Rd, Chandler, AZ 85286 Phone: 480-668-1600 |